Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
91.36 EUR | -0.44% | +4.16% | +1.78% |
01:29pm | SANOFI : Barclays reiterates its Buy rating | ZD |
10:38am | Smith & Nephew CFO designate John Rogers to start next week | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.78% | 124B | |
+35.82% | 701B | |
+26.24% | 571B | |
+1.01% | 381B | |
+20.55% | 334B | |
+16.86% | 319B | |
+1.02% | 210B | |
+2.37% | 210B | |
-6.28% | 201B | |
-3.23% | 157B |
- Stock
- Equities
- Stock Sanofi - Euronext Paris
- News Sanofi
- Sanofi Says Nirsevimab Showed Nearly 80% Efficacy Against Respiratory Syncytial Virus